Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of aminoglycoside analogs in the treatment of Rett syndrome

Use of aminoglycoside analogs in the treatment of Rett syndrome

US Patent 10576095 · Granted Mar 3, 2020

Estimated economic value: $3,900,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified aminoglycoside compounds and uses thereof in disabling bacterial riboso2025
Aminoglycosides and uses thereof in treating genetic disorders2024
Aminoglycoside derivatives and uses thereof in treating genetic disorders2023
Aminoglycoside derivatives and uses thereof in treating genetic disorders2023
Aminoglycoside derivatives and uses thereof in treating genetic disorders2023
Aminoglycoside derivatives and uses thereof in treating genetic disorders2022
Aminoglycosides and uses thereof in treating genetic disorders2021
Aminoglycoside derivatives and uses thereof in treating genetic disorders2021
Aminoglycoside derivatives and uses thereof in treating genetic disorders2021
Aminoglycoside derivatives and uses thereof in treating genetic disorders2020
Aminoglycosides and uses thereof in treating genetic disorders2019
Aminoglycosides and uses thereof in the treatment of genetic disorders2018